Retinoids-the-gold-standard-face-cream-that-nothing-has-yet-replaced
Retinoids — The Gold Standard Face Cream That Nothing Has Yet Replaced
Decades of use, an unmatched base, and a breadth of effect that no newer topical ingredient has come close to replicating. Here is an honest account of what actually do, how the forms compare, and why the option is not always the wisest choice.
A five-decade head start
The story of in begins not with but with acne. Tretinoin ( retinoic acid) was first approved for Acne (just click the following internet site) in the 1960s. Its anti-ageing were almost by accident, as patients and observed that skin treated with looked not just but structurally improved, smoother, firmer, more evenly pigmented, with a of that went well beyond what acne treatment alone could explain.
The decades of into that have one of the most robust bases in all of dermatology. No topical skincare ingredient has been as thoroughly, over as long a period, or with as positive results as retinoic acid and its .
That head start matters clinically. When a patient asks a new might be as as their retinoid, the honest answer almost always begins with an acknowledgement that nothing has had the time, the research investment, or the validation to make that confidently. The newer may be . The retinoid evidence is .
What is a retinoid?
The term "retinoid" refers to the entire family of A derivatives, both natural and synthetic, that share the to bind to acid in the skin and influence gene . The family several that are encountered in clinical and cosmeceutical practice, and their to one is for everything that follows.
At the top of the hierarchy sits tretinoin, all-trans retinoic acid, the fully active form that binds directly to receptors without any .
One step is (also called retinal), which requires a single conversion to become acid.
Two steps removed is retinol — the form most commonly found in over-the-counter — which must be first to retinaldehyde and then to acid before it can exert any biological effect.
Further still are the retinyl esters, & retinyl acetate, which an additional step before entering the .
Beyond these naturally forms sit the synthetic retinoids: adapalene, tazarotene, and the newer (HPR), each designed to interact with specific subtypes or bypass the pathway in different ways.
What retinoids actually do
The breadth of retinoid effect at the cellular and molecular level is, genuinely, remarkable. mechanisms include activity, regulation of and differentiation of cells, activation of fibroblasts, of collagen synthesis and collagen recycling, prevention of loss, reduction in matrix metalloproteinases MMP-1 and MMP-8, and a decrease in epidermal melanin through inhibition of kinase.
Retinoids the of the surface, producing a improvement in skin texture and tone.
They dermal to produce new collagen while simultaneously the enzymes responsible for collagen degradation — a dual action that is particularly valuable in ageing skin where both processes are dysregulated.
They normalise the disordered pigmentation that with sun exposure.
They improve the of the stratum corneum.
And they do all of this through a single, elegantly mechanism: binding to nuclear retinoic acid receptors (RARs) in keratinocytes, triggering a cascade of gene expression changes that affect virtually every aspect of skin biology .
Retinoids are regulators of skin biology, influencing keratinocyte proliferation, differentiation, immune modulation, and barrier .
Their therapeutic has long been attributed to acid receptor-mediated activity; however, recent have additional layers of regulation, epigenetic modifications, kinase signalling networks, and interactions with the skin microbiome. The more closely the mechanism is examined, the more sophisticated it appears.
The sebum question
A word about sebum ( skin oils) — because it is frequently cited as one of retinoids' beneficial and the deserves honest examination.
Oral retinoids, such as used systemically for severe acne, produce a powerful and well-documented reduction in gland activity and sebum production. The same effect in topical is considerably less certain.
The clinical that skin treated with topical becomes less oily may reflect improved surface and normalised keratinocyte turnover rather than a direct in sebum output. The distinction is worth making; not to diminish the value of topical retinoids, whose are and in other respects, but because more than a simplification.
The conversion pathway — and why it matters
Every over-the-counter must be converted, in the skin, to acid before it can bind to the nuclear receptors that drive its biological effects. The skin can only use one form of vitamin A: acid. Everything else is a precursor.
The conversion pathway is sequential and each step introduces . Retinoid activity of the representatives decreases in the following order, from most potent down to weakest:
acid (Tretinoin)
Retinaldehyde
Retinol
esters
Whilst tolerance and hence side effects are the reverse. With Retinyl esters being the gentlest through to Retinoic Acid being the .
In practical terms: retinyl esters, the gentlest and most commonly found form in mass-market moisturisers, must two enzymatic conversion steps before becoming active. Retinol requires two steps. Retinaldehyde requires one. is already in its active form and requires no at all. The further from retinoic acid a retinoid sits in this pathway, the less it delivers the active molecule to the tissue but the less it is in the process.
This is the chemical basis for Dr Forrester’s clinical suspicion that are less effective and the evidence it . Retinol can take twice as long as to begin showing results.
The newer retinoids — genuine advance or elegant marketing?
Hydroxypinacolone retinoate (HPR), known as granactive retinoid, has considerable as a retinoid that supposedly the conversion pathway by to retinoic acid without enzymatic conversion.
The is real. The clinical is . In vitro data suggesting comparable to tretinoin is not the same as in vivo efficacy data in humans over meaningful timeframes — and the latter remains sparse. Reductions in irritation with newer selective are biologically plausible, yet they have not been proven against active comparators in randomised settings.
a more interesting . As the immediate to retinoic acid, it requires only a single conversion step and a more controlled of active retinoic acid than direct .
Metabolism of retinaldehyde to acid occurs only by keratinocytes at a stage of differentiation, to a more controlled delivery of acid and weaker effects compared to . It is, in our view, the most credible of the cosmeceutical retinoids though it suffers from significant instability that have limited its availability in reliably effective products.
The adaptation strategy — getting patients to the effective dose
The most important clinical insight about retinoids is one that is frequently omitted from and recommending practice: the adaptation period is manageable, and managing it well is the between a patient who the full of and one who it after a few weeks of .
In terms: start at the lowest available concentration, apply every third night initially, and support the barrier aggressively throughout with and .
Increase frequency and concentration only when the skin has at the level. The goal is to work up to the most potent form the skin can sustain — not to to the option because it requires the least management.
A patient on tretinoin is demonstrably more biological effect than a on a cosmeceutical retinol at the same subjective level. Getting the first patient to the second patient's tolerance profile is a skill worth in.
The conclusion that the evidence supports
Retinoids remain the best-evidenced ingredient in anti-ageing dermatology. The of their effect — collagen stimulation, epidermal renewal, normalisation, improvement — has not been replicated by any newer in the same depth or over the same . The pathway from to is a of both and tolerability, and the art lies in that in the interest rather than to the most comfortable or the most convenient option.
The newest in the topical — polynucleotides, growth factors, exosomes, — are interesting, and some of them are genuinely . We examine them in the companion piece to this one. None of them has yet earned the right to displace retinoids from their at the of topical . That position has been built over five decades of rigorous research, and it is not easily .
The views in Clinical are the Dr Forrester’s own and reflects his personal and in aesthetic medicine.
References
1. Cosmetic retinoid use in skin: A review of the compounds, their use and mechanisms of action. International Journal of . 2025.
2. A Comprehensive Review of the to Reduce Retinoid-Induced Skin Irritation in Topical . Dermatology Research and . 2024.
3. The Next Generation of Skin Care: Therapeutics. PMC. 2025.
4. An Review of Topical in Dermatology. Journal of Clinical . 2025;14(22):7958.
5. Use of in Topical Antiaging Treatments: A Focused Review. PMC. 2022.
6. in the of skin aging: an overview of clinical efficacy and safety. PMC. 2006.
The Trendy Topicals — Growth Factors, Exosomes, Peptides, NAD, PDRN, and the Rest
The Skin Barrier — What It Is, What It Does, What Disrupts It, and How to Strengthen It
6 Esher Park Avenue
Esher, Surrey KT10 9NP
Tel:
Tel:
© 2026
The Cosmetic Ltd
Company no.